Full List Of Stories
Synairgen posts positive clinical trial data for SNG001
Shares of Synairgen caught a bid following the release of clinical trial results which appeared to show that its SNG001 formulation against Covid-19 might lower the risk of severe disease or death in the most at risk patients.
Tuesday preview: UK employment, Vodafone in focus
The market spotlight on Tuesday will be on UK employment with economists keen to see whether the labour market remains tight and how well - given the ongoing cost-of-living crisis - wage growth is holding up.
Europe close: Stocks end on mixed note amid recession concerns
European shares recovered from early selling but nevertheless finished on a mixed note following very weak industrial production and retail sales figures from China spooked investors worried about a global economic slowdown.
Sector movers: Defensives pace gains
Precious and industrial metals' miners paced gains at the start of the week despite the release of much weaker than expected activity data for the month of April out of the People's Republic of China reflecting the impact of Covid-19 restrictions.
EU Commission slashes GDP growth forecasts, blames war, says worse possible
Brussels axed its short-term growth forecasts for both the European Union and the single currency area, not least as a result of the energy price shock triggered by the war in Ukraine.
Deutsche Bank and JP Morgan lower their target prices for Rolls Royce
Analysts at Deutsche Bank and JP Morgan lowered their target prices for Rolls Royce following medium-term guidance from the aerospace engineer.
London midday: Stocks flat after weak Chinese data, US recession warning
London stocks were little changed come midday despite the release of disappointing Chinese data and warnings that the US could be headed into a recession.
Stocks 'set to recover from here', JP Morgan says
Equities are likely to "recover from here" as long as a recession does not ensue, not least now that the Federal Reserve has reached "peak hawkishness", said strategists at J. P. Morgan.
Chinese economy slows sharply in April as Covid-19 restrictions bite
China's economy slowed much more sharply than anticipated last month as Covid-19 mobility restrictions hampered growth, piling the pressure on policymakers in Beijing - right up to the top according to some accounts.